News & Events NewsPress Releases In the Code Blog In the News Media Kit Press Releases April 28, 2025 Encoded Therapeutics to Present New Data for CNS Gene Therapy Programs at the ASGCT 28th Annual Meeting February 13, 2025 Encoded Therapeutics Reports Clinical Progress of ETX101 Gene Therapy for Dravet Syndrome, Recaps 2024 Corporate Achievements and Provides 2025 Outlook November 07, 2024 Encoded Demonstrates Therapeutic Potential of a Vectorized miRNA-based Approach for Angelman Syndrome at the FAST Annual Global Science Summit View All Press Releases In the Code Blog June 03, 2024 RARECast podcast: Differentiating Gene Therapies through Regulatory Elements Read Full Article October 24, 2023 Our platform to discover and validate regulatory elements to drive targeted transgene expression for use in gene therapies Read Full Article October 13, 2022 Building Customized Gene Expression Profiles Read Full Article View All Blog Articles In the News June 13, 2022 Gene therapy targets interneurons to tackle Dravet syndrome Spectrum May 12, 2022 Gene Therapy’s Commercial Manufacturing Issues — With Encoded Therapeutics’ Andy Stober Cell and Gene Podcast August 10, 2021 Activating SCN1A to Treat Dravet Syndrome GeneTherapyLive View All News Stories Media Kit Logo Leadership Photos Kartik Ramamoorthi, Ph.D. Encoded Co-Founder, CEO and Board Member Stephanie Tagliatela Encoded Co-Founder, Chief Scientific Officer and Board Member Salvador Rico, M.D., Ph.D. Encoded Chief Medical Officer Photos Encoded lab coat Encoded Therapeutics headquarters in South San Francisco Scientists in Encoded’s sequencing lab Scientist in Encoded’s lab Scientist in Encoded’s lab Scientist in Encoded’s lab Download Photo Archive Video Footage